S&P 500   2,967.82 (-0.08%)
DOW   26,816.30 (0.00%)
QQQ   191.24 (+0.07%)
AAPL   236.53 (+0.13%)
FB   183.43 (-0.41%)
MSFT   139.56 (-0.09%)
CGC   18.84 (-3.04%)
MU   44.89 (-0.47%)
BABA   171.80 (-0.66%)
GE   8.77 (-0.45%)
AMD   30.43 (+2.29%)
T   37.42 (-0.43%)
F   8.81 (+0.34%)
PRI   121.10 (-0.48%)
NFLX   285.50 (+0.91%)
BAC   29.03 (+0.42%)
DIS   129.50 (-0.40%)
S&P 500   2,967.82 (-0.08%)
DOW   26,816.30 (0.00%)
QQQ   191.24 (+0.07%)
AAPL   236.53 (+0.13%)
FB   183.43 (-0.41%)
MSFT   139.56 (-0.09%)
CGC   18.84 (-3.04%)
MU   44.89 (-0.47%)
BABA   171.80 (-0.66%)
GE   8.77 (-0.45%)
AMD   30.43 (+2.29%)
T   37.42 (-0.43%)
F   8.81 (+0.34%)
PRI   121.10 (-0.48%)
NFLX   285.50 (+0.91%)
BAC   29.03 (+0.42%)
DIS   129.50 (-0.40%)
Log in

Silk Road Medical Stock Price, News & Analysis (NASDAQ:SILK)

$30.99
-0.16 (-0.51 %)
(As of 10/14/2019 01:42 PM ET)
Today's Range
$30.77
Now: $30.99
$31.29
50-Day Range
$28.38
MA: $36.28
$43.70
52-Week Range
$27.83
Now: $30.99
$51.50
Volume3,049 shs
Average Volume347,875 shs
Market Capitalization$953.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SILK
CUSIPN/A
CIKN/A
Phone408-720-9002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$34.56 million

Profitability

Miscellaneous

Employees176
Market Cap$953.25 million
Next Earnings Date11/4/2019 (Estimated)
OptionableNot Optionable

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.


Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

How were Silk Road Medical's earnings last quarter?

Silk Road Medical Inc (NASDAQ:SILK) announced its earnings results on Monday, July, 29th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by $0.14. The business earned $14.93 million during the quarter, compared to analysts' expectations of $13.64 million. Silk Road Medical's revenue was up 92.2% on a year-over-year basis. View Silk Road Medical's Earnings History.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Silk Road Medical.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2019 earnings guidance on Monday, July, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $60-62 million, compared to the consensus revenue estimate of $60.17 million.

What price target have analysts set for SILK?

5 analysts have issued 12 month price targets for Silk Road Medical's stock. Their forecasts range from $40.01 to $52.00. On average, they expect Silk Road Medical's share price to reach $44.80 in the next year. This suggests a possible upside of 44.6% from the stock's current price. View Analyst Price Targets for Silk Road Medical.

What is the consensus analysts' recommendation for Silk Road Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Silk Road Medical.

Has Silk Road Medical been receiving favorable news coverage?

Media coverage about SILK stock has trended negative on Monday, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Silk Road Medical earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Silk Road Medical.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a increase in short interest in September. As of September 30th, there was short interest totalling 2,320,000 shares, an increase of 58.9% from the August 30th total of 1,460,000 shares. Based on an average daily trading volume, of 306,800 shares, the days-to-cover ratio is currently 7.6 days. Currently, 14.3% of the shares of the stock are short sold. View Silk Road Medical's Current Options Chain.

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Splunk (SPLK), Alibaba Group (BABA), Home Depot (HD), Thermo Fisher Scientific (TMO), DexCom (DXCM), Paypal (PYPL), Workday (WDAY), salesforce.com (CRM), Cisco Systems (CSCO) and Netflix (NFLX).

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the folowing people:
  • Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)
  • Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)
  • Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)
  • Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)
  • Ms. Alison Highlander, VP of HR

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

When did the company's lock-up period expire?

Silk Road Medical's lock-up period expired on Tuesday, October 1st. Silk Road Medical had issued 6,000,000 shares in its IPO on April 4th. The total size of the offering was $120,000,000 based on an initial share price of $20.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $30.99.

How big of a company is Silk Road Medical?

Silk Road Medical has a market capitalization of $953.25 million and generates $34.56 million in revenue each year. Silk Road Medical employs 176 workers across the globe.View Additional Information About Silk Road Medical.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is http://silkroadmed.com/.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]


MarketBeat Community Rating for Silk Road Medical (NASDAQ SILK)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  45
MarketBeat's community ratings are surveys of what our community members think about Silk Road Medical and other stocks. Vote "Outperform" if you believe SILK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SILK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel